PR PolyResearch

Join Free

NASDAQ

Ernexa Therapeutics Inc. (ERNA)

♥ 648 Thanks from members

Ernexa Therapeutics Inc. (ERNA) exhibits high volatility, driven by positive preclinical validation for ERNA-101 and a tight 668K float, offset by acute cash burn, a $9.5M six-month loss, and reliance on ATM dilution.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)